Gene: RENBP
Official Full Name: renin binding proteinprovided by HGNC
Gene Summary: The gene product inhibits renin activity by forming a dimer with renin, a complex known as high molecular weight renin. The encoded protein contains a leucine zipper domain, which is essential for its dimerization with renin. The gene product can catalyze the interconversion of N-acetylglucosamine to N-acetylmannosamine, indicating that it is a GlcNAc 2-epimerase. Transcript variants utilizing alternative promoters have been described in the literature. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35662 | RENBP Knockout cell line (HEK293) | Human | RENBP | 1:3~1:6 | Negative | Online Inquiry |
RENBP Gene Knockout Cell Lines are advanced cellular models designed specifically to facilitate the study of the RENBP gene and its associated pathways. By employing CRISPR-Cas9 gene-editing technology, these cell lines have been precisely engineered to lack functional RENBP, allowing researchers to investigate the gene's contributions to cellular functions, interactions, and overall biological mechanisms.
The key functionality of RENBP Gene Knockout Cell Lines lies in their ability to elucidate the role of the RENBP protein in various physiological and pathological contexts. By observing the phenotypic and molecular changes that arise upon gene knockout, researchers can gain valuable insights into the gene's implications in diseases such as cancer, cardiovascular disorders, and metabolic syndromes. This targeted approach enhances our understanding of RENBP’s biological significance and its potential as a therapeutic target.
From a scientific perspective, these cell lines are crucial tools in both research and clinical applications. They enable high-throughput screening for drug discovery, identification of genetic interactions, and validation of therapeutic strategies aimed at modulating gene function. Furthermore, the specificity of the knockout ensures that results are attributable to the target gene, enhancing the rigor and reproducibility of experiments.
Unique selling points of our RENBP Gene Knockout Cell Lines include their high efficiency and reliability, supported by a robust characterization process that confirms the complete knockout of RENBP. Unlike other alternatives on the market, our product is optimized for ease of use and integration into existing experimental workflows, enabling researchers to harness their full potential without the complexities often associated with gene editing.
For researchers and clinicians striving to unravel the complexities of gene function within their fields, RENBP Gene Knockout Cell Lines are indispensable resources that elevate both the quality and impact of scientific inquiry. Our company's commitment to innovation in biological research products, combined with extensive expertise in gene editing technologies, positions us as a leader in delivering exceptional tools that drive discoveries and improve human health.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.